U.S. markets closed

Pro Medicus Limited (PME.AX)

ASX - ASX Delayed Price. Currency in AUD
71.67-0.70 (-0.97%)
At close: 04:10PM AEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close72.37
Bid71.66 x 21400
Ask71.69 x 12000
Day's Range71.04 - 72.05
52 Week Range49.25 - 74.99
Avg. Volume147,656
Market Cap7.559B
Beta (5Y Monthly)0.60
PE Ratio (TTM)123.57
EPS (TTM)0.58
Earnings DateAug 15, 2023
Forward Dividend & Yield0.34 (0.47%)
Ex-Dividend DateSep 06, 2023
1y Target Est70.31
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for PME.AX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Simply Wall St.

      53% of Pro Medicus Limited (ASX:PME) is owned by insiders, and they've been buying recently

      Key Insights Significant insider control over Pro Medicus implies vested interests in company growth The top 2...

    • Simply Wall St.

      Pro Medicus Full Year 2023 Earnings: Beats Expectations

      Pro Medicus ( ASX:PME ) Full Year 2023 Results Key Financial Results Revenue: AU$127.3m (up 35% from FY 2022). Net...

    • PR Newswire

      Visage 7 Named Best in KLAS 2023

      Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the Visage® 7 Enterprise Imaging Platform ("Visage 7") has been ranked the #1 Universal Viewer (Imaging) in the 2023 Best in KLAS ® Software & Services Report by KLAS Research ("KLAS"). Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform, delivered entirely from the cloud or